Skip to content

The effects of systematic strength training and time-restricted eating on strength capacity, body composition and metabolism in individuals with metabolic syndrom - a 16 week randomized control trial

The effects of systematic strength training and time-restricted eating on strength capacity, body composition and metabolism in individuals with metabolic syndrom - a 16 week randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00040337
Enrollment
30
Registered
2026-05-12
Start date
2025-05-19
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Individuals with metabolic syndrom

Interventions

Group 1: People with metabolic syndrome who undertake a structured strength training programme (3 times a week) for 16 weeks Group 2: People with metabolic syndrome who undertake a structured strength

Sponsors

IST Hochschule für Management
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All participants undergo a stress ECG before the study begins and are assessed by their GP as fit for exercise. All participants are already physically active and train at a gym, and will be given a new, tailored training plan. In addition, they have been trained to take capillary blood samples from their fingertips themselves. • Men and women aged 18 or over, registered at a gym • Abdominal obesity with a waist circumference >80cm for women or 94cm for men Plus 2 of the following factors - Elevated triglycerides > 150mg/dl (1.7mmol/L) - Low HDL cholesterol: women 130 mmHg or diastolic 100 mg/dl (5.6 mmol/L)

Exclusion criteria

Exclusion criteria: • Overt type 2 diabetes mellitus • Acute hypothyroidism (< 2 years) • Pregnancy (up to six months prior to the start of the study) • Gynaecological conditions • Heart failure (EF < 55) • Performance-limiting peripheral arterial disease (Fontaine stage = II) • Unbalanced diet • Cardiac arrhythmias requiring treatment • Performance- or training-limiting degenerative joint diseases or muscular disorders • Performance-limiting kidney disease • Performance-limiting neurological disorder • History of oncological diseases (< 5 years) • Psychiatric and/or substance use disorders

Design outcomes

Primary

MeasureTime frame
At the start (T0), and after 4 (T1), 8 (T2), 12 (T3) and 16 (T4) weeks, isometric strength tests for trunk flexion, extension, leg flexion and extension, as well as grip strength, will be assessed for all participants. Following two warm-up sets, the maximum contraction will be measured three times. In addition, at the same time points, body composition, BMI, muscle mass and fat mass are assessed using bioelectrical impedance analysis (Tanita, MC-780MA-N).

Secondary

MeasureTime frame
Capillary blood samples are taken at time points T0, T2 and T4, and HbA1c, cholesterol, LDL, HDL and their ratios, as well as TSH, are then measured (ISO/IEC 17025 and ISO 15189)

Countries

Germany

Contacts

Public ContactEduard Isenmann

IST Hochschule für Management

eisenmann@ist-hochschule.de+49

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026